1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow Unresectable Leiomyosarcoma: new trials by email Literature Review of Unresectable Leiomyosarcoma trials Research Report on Unresectable Leiomyosarcoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by Surgery Doxorubicin Hydrochloride, Laboratory Biomarker Analysis, Pharmacological Study - Advanced Soft Tissue Sarcoma, Locally Advanced Angiosarcoma | Phase 1 | Completed | OHSU Knight Cancer Institute | 16 | 2017-03-10 | 2023-08-16 |
Dermatofibrosarcoma (1) · Disorders of Sex Development (1) · Fibrosarcoma (1) · Hemangiosarcoma (1) · Histiocytoma, Malignant Fibrous (1) · Liposarcoma (1) · Neurofibrosarcoma (1) · Sarcoma (1) · Sarcoma, Synovial (1)
Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Endocrine System Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Gonadal Disorders (1) · Histiocytoma (1) · Male Urogenital Diseases (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Adipose Tissue (1) · Neoplasms, Connective Tissue (1) · Neoplasms, Connective and Soft Tissue (1) · Neoplasms, Fibrous Tissue (1) · Neoplasms, Nerve Tissue (1)
Doxorubicin (1) · ribociclib (1)
OHSU Knight Cancer Institute (1)
United States (1)
Lara E Davis (1)